(Q48630413)

13 February 2018

title

NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. (English)

1 reference

13 February 2018

Vincent Richard

7

0 references

author name string

Marc Isabelle

1

1 reference

13 February 2018

Aurélia Vergeade

2

1 reference

13 February 2018

Fabienne Moritz

3

1 reference

13 February 2018

Brigitte Dautréaux

4

1 reference

13 February 2018

Jean-Paul Henry

5

1 reference

13 February 2018

Françoise Lallemand

6

1 reference

13 February 2018

Paul Mulder

8

1 reference

13 February 2018

Christian Thuillez

9

1 reference

13 February 2018

Christelle Monteil

10

1 reference

13 February 2018

publication date

10 January 2007

1 reference

13 February 2018

Journal of Molecular and Cellular Cardiology

published in

1 reference

13 February 2018

volume

42

1 reference

13 February 2018

issue

2

1 reference

13 February 2018

page(s)

326-332

1 reference

13 February 2018

Cardiovascular complications of cocaine use.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Effect of cocaine on cardiac biochemical functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Markers of cardiac oxidative stress and altered morphology after intraperitoneal cocaine injection in a rat model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Role of reactive oxygen species in cocaine-induced cardiac dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Cocaine, Not Morphine, Causes the Generation of Reactive Oxygen Species and Activation of NF-κB in Transiently Cotransfected Heart Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Vascular NADPH oxidases: molecular mechanisms of activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Role of alpha1-adrenoreceptors in cocaine-induced NADPH oxidase expression and cardiac dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Structure and function of xanthine oxidoreductase: where are we now?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

NADPH oxidase and endothelial cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

NAD(P)H oxidase: role in cardiovascular biology and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

41 Preparation and assay of superioxide dismutases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Cysteines involved in the interconversion between dehydrogenase and oxidase forms of bovine xanthine oxidoreductase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

Peroxynitrite induces the conversion of xanthine dehydrogenase to oxidase in rabbit liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.011

10.1016/J.YJMCC.2006.11.011

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

17217956

1 reference

13 February 2018